These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2031430)

  • 1. The selection of optimal vasodilator drugs in heart failure based on noninvasive parameters.
    Dékány M; Vándor L; Bányai F; Balogh I; Kékes E; Antaloczy Z
    Acta Cardiol; 1991; 46(1):85-6. PubMed ID: 2031430
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of captopril on the immediate quality of life in patients with congestive heart failure].
    Han Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 1992 Jun; 20(3):154-6. PubMed ID: 1289024
    [No Abstract]   [Full Text] [Related]  

  • 3. [Vasodilator agents in the treatment of cardiac insufficiency].
    Bertel O
    Ther Umsch; 1984 Feb; 41(2):117-24. PubMed ID: 6424258
    [No Abstract]   [Full Text] [Related]  

  • 4. [Non-invasive assessment of the efficacy of long-term vasodilator therapy of cardiac decompensation in patients with dilated cardiomyopathy].
    Riecanský I; Schreinerová Z; Bzdúchová O; Plachá L; Havlínová K; Zelenay J
    Bratisl Lek Listy; 1993 Sep; 94(9):478-82. PubMed ID: 8004497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Acute and long-term effects of captopril in patients with left ventricular dysfunction and dilatation: evaluation of function and work capacity].
    Foresti A; Bertoni T; Gentile G; Kheir A; Nardi B; Lotto A
    G Ital Cardiol; 1989 Nov; 19(11):999-1006. PubMed ID: 2695386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on the short-term effects of angiotensin converting enzyme inhibitors (Lopirin, SQUIBB and Tensiomin), and dihydralazine in chronic cardiac failure.
    Dékány M; Bányai F; Antalóczy Z
    Acta Physiol Hung; 1988; 72 Suppl():93-110. PubMed ID: 3075406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Captopril (Tensiomin) in the treatment of chronic heart failure of ischaemic heart disease patients.
    Palócz E; Kerkovits G
    Ther Hung; 1989; 37(4):220-4. PubMed ID: 2698519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemodynamic, radionuclide ventriculography and ergometric evaluation of captopril treatment in congestive heart failure.
    Gronda E; Brusoni B; Mangiavacchi M; Oppizzi M; Inglese E; Caroli A; Rovelli F
    Postgrad Med J; 1986; 62 Suppl 1():167-9. PubMed ID: 3534856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal left ventricular systolic and diastolic functional response to isometric exercise in idiopathic dilated cardiomyopathy: beneficial effect of captopril.
    Shen W; Zhang X; Hu H; Gong L
    Chin Med Sci J; 1995 Dec; 10(4):232-6. PubMed ID: 8745586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Captopril in the treatment of severe circulatory insufficiency resistant to digitalis preparations and diuretics].
    Wiernikowski A; Michajlik A; Wysznacka-Aleksandrow W
    Pol Tyg Lek; 1984 Dec; 39(50):1657-9. PubMed ID: 6396593
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of carvedilol therapy on myocardial functional reserve in patients with advanced heart failure caused by nonischemic dilated cardiomyopathy.
    Paraskevaidis IA; Tsiapras D; Karavolias G; Adamopoulos S; Dodouras T; Cokkinos P; Kremastinos DT
    J Am Soc Echocardiogr; 2006 May; 19(5):529-35. PubMed ID: 16644436
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term vasodilator therapy for heart failure: noninvasive evaluation and noninvasive predictors of survival.
    Riecansky I
    Acta Cardiol; 1995; 50(3):209-13. PubMed ID: 7676760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Severe circulatory insufficiency in congestive cardiomyopathy treated successfully with captopril].
    Manitius J; Gross E; Koprowski A; Wyrzykowski B
    Wiad Lek; 1984 Jul; 37(14):1105-8. PubMed ID: 6393590
    [No Abstract]   [Full Text] [Related]  

  • 14. [Exercise testing in heart failure; utility and limitations].
    Straburzyńska-Migaj E; Szyszka A; Cieśliński A
    Kardiol Pol; 2003 Jan; 58(1):77-9. PubMed ID: 14502312
    [No Abstract]   [Full Text] [Related]  

  • 15. Captopril in mild heart failure: preliminary observations of a long-term, double-blind, placebo-controlled multicentre trial.
    Magnani B; Magelli C
    Postgrad Med J; 1986; 62 Suppl 1():153-8. PubMed ID: 3534852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute and chronic effects of dihydralazine in severe congestive heart failure at rest and during exercise (author's transl)].
    Reifart N; Bunge T; Kaltenbach M; Bussmann WD
    Z Kardiol; 1982 Jan; 71(2):75-81. PubMed ID: 6803467
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical issues in the management of heart failure.
    Boccanelli A; Scardovi AB
    G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133
    [No Abstract]   [Full Text] [Related]  

  • 18. [Differentiation of ischemic cardiomyopathy from idiopathic dilated cardiomyopathy. Evaluation of the value of radionuclide imaging].
    Kurihara T; Narita M; Murano K; Usami M; Honda M; Kanao K
    Kaku Igaku; 1985 Jan; 22(1):49-55. PubMed ID: 3999455
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of vasodilator agents in circulatory insufficienty].
    Halawa B
    Wiad Lek; 1979 Nov; 32(22):1617-20. PubMed ID: 120075
    [No Abstract]   [Full Text] [Related]  

  • 20. [Current aspects of the clinical effectiveness and tolerance of captopril in the treatment of cardiovascular diseases].
    Ol'binskaia LI; Mokhova OV
    Ter Arkh; 1984; 56(11):139-42. PubMed ID: 6395426
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.